News
The tool is less apt to overestimate ASCVD risk than the pooled cohort equations and in turn could reduce overtreatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback